FindTrial
Sign In

BRCA mutation in patients with ovarian cancer in Korea

Prevalence of BRCA mutation in Korean woman with ovarian cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005463
Enrollment
108
Registered
2020-10-12
Start date
2016-02-24
Completion date
Unknown
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who underwent testing for a BRCA gene mutation after being diagnosed with epithelial ovarian cancer between January 2010 and December 2015 in hospitals affiliated with the Catholic University of Korea

Exclusion criteria

Exclusion criteria: Patients with incomplete medical records

Design outcomes

Primary

MeasureTime frame
Prevalence of BRCA mutation in Korean ovarian cancer patients—

Secondary

MeasureTime frame
Progression-free and overall survival according to BRCA mutation status—

Countries

Korea, Republic of

Contacts

Public ContactJi Geun Yoo

The Catholic University of Korea

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026